Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

被引:47
|
作者
Kato, Tomoko S. [1 ]
Takayama, Hiroo [2 ]
Yoshizawa, Saeko [3 ]
Marboe, Charles [3 ]
Schulze, P. Christian [1 ]
Farr, Maryjane [1 ]
Naka, Yoshifumi [2 ]
Mancini, Donna [1 ]
Maurer, Mathew S. [1 ]
机构
[1] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY 10027 USA
[2] Columbia Univ, Dept Surg, Div Cardiothorac Surg, Med Ctr, New York, NY USA
[3] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA
关键词
MUSCLE CELL DISORGANIZATION; LEFT-VENTRICULAR HYPERTROPHY; HEART-TRANSPLANTATION; CLINICAL-SIGNIFICANCE; ATHLETES HEART; SURVIVAL; PREVALENCE; INFECTION; DIAGNOSIS; FEATURES;
D O I
10.1016/j.amjcard.2012.04.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac transplantation is a treatment option for patients with hypertrophic cardiomyopathy (HC) who developed refractory heart failure and/or intractable arrhythmia. However, the pretransplant characteristics and post-transplant prognosis for patients with nondilated idiopathic HC has not yet fully elucidated. Therefore, we retrospectively reviewed 813 consecutive transplant recipients undergoing cardiac transplantation at Columbia University Medical Center from 1999 to 2010 and compared the clinical course of 41 patients with idiopathic HC with that of 373 patients with ischemic heart disease and 398 patients with other heart disease. The patients with HC were younger than those with ischemic heart disease (47.8 +/- 14.0 vs 57.1 +/- 9.4 years; p <0.0001). The proportion of patients undergoing ventricular assist devise surgery for bridge-to-transplant was lower in patients with HC than in those with ischemic heart disease or other heart disease (14.6% vs 31.1% vs 35.7%, all p <0.01). The post-transplant survival of those with HC was better than that for those with ischemic heart disease (90.1% vs 85.8% and 83.9% vs 67.1% at 1 and 5 years, respectively; p = 0.0359), although it was not significantly different from those with other heart disease. Proportional hazards analysis revealed that the subjects with HC had reduced post-transplant mortality (hazard ratio 0.4760, 95% confidential interval 0.1889 to 0.9762; p = 0.042) on univariate, but not multivariate, analysis. Most patients with HC had nondilated left ventricles (left ventricular end-diastolic dimension <= 55 mm; n = 27), and post-transplant survival did not differ from that for those with dilated left ventricles (left ventricular end-diastolic dimension >55 mm; n = 14). In conclusion, the post-transplant survival of those with HC did not differ from those of the subjects who underwent transplant for other non-HC indications. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:568-574)
引用
收藏
页码:568 / 574
页数:7
相关论文
共 50 条
  • [21] Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure
    Nguyen, Anita
    Schaff, Hartzell, V
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Dearani, Joseph A.
    King, Katherine S.
    Ommen, Steve R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 159 (01) : 145 - 152
  • [22] Nuclear cardiac imaging in hypertrophic cardiomyopathy
    Shirani, Jamshid
    Dilsizian, Vasken
    JOURNAL OF NUCLEAR CARDIOLOGY, 2011, 18 (01) : 123 - 134
  • [23] CARDIAC-ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
    BJARNASON, I
    HARDARSON, T
    JONSSON, S
    BRITISH HEART JOURNAL, 1982, 48 (03): : 198 - 203
  • [24] Sudden Cardiac Death in Hypertrophic Cardiomyopathy
    O'Mahony, Constantinos
    Elliott, Perry
    McKenna, William
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (02) : 443 - 451
  • [25] MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients
    Mouton, J. M.
    van der Merwe, L.
    Goosen, A.
    Revera, M.
    Brink, P. A.
    Moolman-Smook, J. C.
    Kinnear, C.
    HUMAN GENETICS, 2016, 135 (05) : 477 - 483
  • [26] Uric acid is associated with cardiac death in patients with hypertrophic obstructive cardiomyopathy
    Gao, Jun
    Shao, Chun-Li
    Meng, Xiang-Bin
    Wang, Wen-Yao
    Zhang, Kuo
    Wang, Jing-Jia
    Zheng, Ming-Qi
    Tang, Yi-Da
    JOURNAL OF GERIATRIC CARDIOLOGY, 2021, 18 (04) : 281 - 288
  • [27] Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy
    Francia, Pietro
    Silvetti, Giacomo
    Cosentino, Pietro
    Cristiano, Ernesto
    Adduci, Carmen
    Tini, Giacomo
    Musumeci, Maria Beatrice
    Volpe, Massimo
    Autore, Camillo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 366 : 42 - 47
  • [28] The Value of Cardiac Magnetic Resonance Imaging in Identification of Rare Diseases Mimicking Hypertrophic Cardiomyopathy
    Fang, Tingting
    Wang, Jie
    Kang, Yu
    Yang, Fuyao
    Xu, Yuanwei
    Wan, Ke
    Sun, Jiayu
    Han, Yuchi
    Chen, Yucheng
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [29] Cardiac Myosin Inhibitors: Expanding the Horizon for Hypertrophic Cardiomyopathy Management
    Sykuta, Alyssa
    Yoon, Connie H.
    Baldwin, Sarah
    Rine, Natalie I.
    Young, Michael
    Smith, Adam
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (03) : 273 - 285
  • [30] Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy
    Nojiri, Ayumi
    Hongo, Kenichi
    Kawai, Makoto
    Komukai, Kimiaki
    Sakuma, Toru
    Taniguchi, Ikuo
    Yoshimura, Michihiro
    JOURNAL OF CARDIOLOGY, 2011, 58 (03) : 253 - 260